UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Pitfalls in thyroid tumour pathology

Histopathology, 2006-08, Vol.49 (2), p.107-120

2006

Volltextzugriff (PDF)

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Annals of oncology, 2009-04, Vol.20 (4), p.741-745

2009

Volltextzugriff (PDF)

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

Clinical cancer research, 1998-02, Vol.4 (2), p.287-294

1998

Volltextzugriff (PDF)

Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma

Cancer research (Chicago, Ill.), 1999-04, Vol.59 (8), p.1811-1815

1999

Volltextzugriff (PDF)

Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction

Nature genetics, 1999-02, Vol.21 (2), p.182-186

1999

Volltextzugriff (PDF)

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

Annals of oncology, 2008-10, Vol.19 (10), p.1706-1712

2008

Volltextzugriff (PDF)

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

Journal of clinical oncology, 1993-03, Vol.11 (3), p.485-490

1993

Volltextzugriff (PDF)

Alterations in Notch Signaling in Neoplastic Lesions of the Human Cervix

Proceedings of the National Academy of Sciences - PNAS, 1995-07, Vol.92 (14), p.6414-6418

1995

Volltextzugriff (PDF)

Follicular Hurthle cell tumors of the thyroid gland

Cancer, 1991-11, Vol.68 (9), p.1944-1953

1991

Volltextzugriff (PDF)

Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study

European journal of surgical oncology, 2017-11, Vol.43 (11), p.2012-2020

2017

Volltextzugriff (PDF)

Stage IA uterine serous carcinoma : A study of 13 cases

The American journal of surgical pathology, 1997-12, Vol.21 (12), p.1507-1514

1997

Volltextzugriff (PDF)

Management of breast cancer after Hodgkin’s lymphoma and paediatric cancer

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1667-1674

2015

Volltextzugriff (PDF)

Genetic analysis of benign, low-grade, and high-grade ovarian tumors

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (24), p.6172-6180

1995

Volltextzugriff (PDF)

Human Ligands of the Notch Receptor

The American journal of pathology, 1999-03, Vol.154 (3), p.785-794

1999

Volltextzugriff (PDF)

Microsatellite instability in ovarian neoplasms

British journal of cancer, 1995-08, Vol.72 (2), p.376-382

1995

Volltextzugriff (PDF)

Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?

Fertility and sterility, 1998-09, Vol.70 (3), p.580-587

1998

Volltextzugriff (PDF)

Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1

Clinical cancer research, 1997-06, Vol.3 (6), p.999-1007

1997

Volltextzugriff (PDF)

Plasminogen activator inhibitor‐1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

International journal of cancer, 1998-10, Vol.79 (5), p.449-454

1998

Volltextzugriff (PDF)

Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38–45]

Cancer genetics, 2018-12, Vol.228-229, p.128-128

2018

Volltextzugriff (PDF)

Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance

The Journal of pathology, 2000-03, Vol.190 (4), p.470-477

2000

Volltextzugriff (PDF)

Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor

American journal of clinical pathology, 2000-04, Vol.113 (4), p.572-575

2000

Volltextzugriff (PDF)

37 Reducing overtreatment of early stage ovarian cancer: strategies implementation by a mirna-driven prognostic assessment

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A22-A23

2019

Volltextzugriff (PDF)

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

The American journal of pathology, 2001-03, Vol.158 (3), p.987-996

2001

Volltextzugriff (PDF)

Pathogenesis of Placental Site Trophoblastic Tumor May Require the Presence of a Paternally Derived X Chromosome

Laboratory investigation, 2000-06, Vol.80 (6), p.965-972

2000

Volltextzugriff (PDF)

Follicular Hurthle cell tumors of the thyroid gland

Cancer, 1991-11, Vol.68 (9), p.1944-1953

1991

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(209)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pitfalls in thyroid tumour pathology

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma

Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

Alterations in Notch Signaling in Neoplastic Lesions of the Human Cervix

Follicular Hurthle cell tumors of the thyroid gland

Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study

Stage IA uterine serous carcinoma : A study of 13 cases

Management of breast cancer after Hodgkin’s lymphoma and paediatric cancer

Genetic analysis of benign, low-grade, and high-grade ovarian tumors

Human Ligands of the Notch Receptor

Microsatellite instability in ovarian neoplasms

Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?

Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1

Plasminogen activator inhibitor‐1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38–45]

Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance

Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor

37 Reducing overtreatment of early stage ovarian cancer: strategies implementation by a mirna-driven prognostic assessment

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

Pathogenesis of Placental Site Trophoblastic Tumor May Require the Presence of a Paternally Derived X Chromosome

Follicular Hurthle cell tumors of the thyroid gland

Suchergebnisse filtern